Effect of HPV Education on Women's Knowledge

NCT07231263 | Not Yet Recruiting

• 1 other identifier: 2025/23/04
• Study Type: interventional
• Target: 110
• Locations: 0 countries
• Sites: N/A

Brief Summary

This interventional study aims to evaluate the effectiveness of an educational program on women's knowledge of Human Papillomavirus (HPV), HPV vaccination, and screening. HPV is a major public health concern worldwide and a leading cause of cervical cancer. Although cervical cancer is preventable through vaccination and early screening, HPV awareness among women remains limited in Türkiye. Educational interventions are therefore essential to improve knowledge and promote preventive health behaviors. The study population consists of 110 women attending courses at the Suzan and Abdulhakim Bilgili Public Education Center in Onikişubat, Kahramanmaraş, Türkiye, between August 2025 and December 2025. No formal sample size calculation was performed. Instead, 80 women who met the inclusion criteria and voluntarily agreed to participate were included in the study. Participants were randomly assigned to either the intervention group (education) or the control group (no education). The HPV education program is delivered in two 1-hour sessions using PowerPoint presentations and informational brochures developed from current literature and reviewed by experts in women's health nursing. Data are collected before and after the educational sessions using a Personal Information Form and the HPV Knowledge Scale (HPV-KS), which measures participants' knowledge about HPV infection, vaccination, and screening. Statistical analyses will be conducted using SPSS 22.0, with descriptive statistics and inferential tests (paired-sample t-test, independent-sample t-test, repeated-measures ANOVA, and non-parametric equivalents) applied as appropriate. A p-value \< 0.05 will be considered statistically significant. It is hypothesized that women receiving HPV education will demonstrate significantly higher post-intervention knowledge scores compared to those in the control group.

Conditions

Human Papillomavirus (HPV); Awareness and Knowledge Level

Keywords

Human papillomavirus (HPV); HPV education; Women's health;

Outcome Measures

Primary Outcomes (1)

• HPV knowledge level measured by the Human Papillomavirus Knowledge Scale (HPV-BÖ)

  his outcome will assess changes in participants' knowledge about HPV, HPV vaccination, HPV screening tests, and the national vaccination program using the HPV Knowledge Scale adapted to Turkish women. The scale consists of 33 items scored as 0-33, with higher scores indicating higher knowledge.

  Baseline (pre-test) and immediately after the education session (post-test)

Secondary Outcomes (4)

• General HPV knowledge measured by the HPV Knowledge Scale (HPV-BÖ) - Subscale 1

  Baseline and immediately after the intervention

• Knowledge of HPV screening tests measured by the HPV Knowledge Scale (HPV-BÖ) - Subscale 2

  Baseline and immediately after the intervention

• Knowledge of HPV vaccination measured by the HPV Knowledge Scale (HPV-BÖ) - Subscale 3

  Baseline and immediately after the intervention

• Knowledge of the national HPV vaccination program measured by the HPV Knowledge Scale (HPV-BÖ) - Subscale 4

  Baseline and immediately after the intervention

Study Arms (2)

HPV Awareness Education Group

EXPERIMENTAL

Other: HPV Awareness Education Group

Control Group

NO INTERVENTION

Interventions

HPV Awareness Education Group OTHER

Women who agree to participate in the training will receive a total of two hours of HPV awareness training in two sessions on the predetermined training date. The HPV awareness training will be delivered using a PowerPoint presentation, and at the end of the training, a brochure created in line with the literature will be distributed to the participating women to ensure retention. The brochure will be prepared by the researcher based on current literature sources. Expert opinions will be sought from specialists in the field of obstetrics and gynecology nursing regarding the training content, and revisions will be made if necessary. The training content will include the definition of HPV, risk factors, etiology, screening, HPV vaccination, transmission and prevention methods, and treatment. The training topics will be prepared by the faculty members responsible for the research in accordance with the literature.

HPV Awareness Education Group

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years of age or older,
• Agreeing to participate in the study,
• Not experiencing communication difficulties,
• Female students who complete the data collection form in full will be included in the study.

You may not qualify if:

• Previously tested positive for HPV
• History of cervical cancer
• Unreachable
• Not attending public education during the training period
• Female students who did not complete the data collection form will be excluded from the study.

Sponsors & Collaborators

• Kahramanmaras Sutcu Imam University: lead

Related Publications (1)

• 1. World Health Organization-WHO. Updates recommendations on HpV vacci- nation schedule

  BACKGROUND

Central Study Contacts

Fatma Keskin Töre

CONTACT

0 344 300 26 06; keskinfatma989@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: ASSOCIATE PROFESSOR

Study Record Dates

• First Submitted: November 13, 2025
• First Posted: November 17, 2025
• Study Start: November 14, 2025
• Primary Completion: November 30, 2025
• Study Completion: November 30, 2025
• Last Updated: November 17, 2025

Record last verified: 2025-11